» Articles » PMID: 24350891

Intraoperative Parathyroid Hormone Level in Parathyroidectomy: Which Patients Benefit from It?

Overview
Publisher Sage Publications
Date 2013 Dec 20
PMID 24350891
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intraoperative parathyroid hormone level (IOPTH) is withdrawn during parathyroidectomy to confirm the success of the procedure. Recently, the importance of IOPTH has been put to question. The purpose of this study is to determine whether IOPTH is necessary for all patients undergoing parathyroidectomy in the presence of frozen section.

Materials And Methods: A cohort study of parathyroidectomies was performed in three university affiliated hospitals during 2007-2012. The patients were divided into two groups. Group 1: Patients with two preoperative concordant imaging localizing a hyperactive gland. Group 2: Patients without two concordant imaging. A comparison of benefit of IOPTH was carried out. Frozen section results were also analyzed to determine sensitivity and predictability of a parathyroid adenoma.

Results: The study considered 221 patients having parathyroidectomies for primary hyperparathyroidism (PHPT). Of them, 10 were excluded due to incomplete data. Among the remaining, 186 had 2 concordant imaging preoperatively localizing an adenoma. 93.5% of whom were found intraoperatively in that location. IOPTH was not found to be of importance in 98.92% of the preoperative localized adenomas in the presence of frozen section. IOPTH added an estimate of 30.9 minutes on average to the surgery time.

Conclusion: This study demonstrates that the added operating time associated with IOPTH may not be justified for patients undergoing parathyroidectomy who have 2 concordant imaging preoperatively in the presence of frozen section. This study suggests a simple algorithm, The McGill Parathyroid Protocol (MPP), to help in approaching PHPT patients undergoing parathyroidectomy.

Citing Articles

Surgical Treatment for Parathyroid Adenoma: A Case Report.

Prihantono P, Palinggi E, Haryasena H, Hamdani W, Binekada I Open Access Maced J Med Sci. 2019; 7(15):2497-2501.

PMID: 31666854 PMC: 6814464. DOI: 10.3889/oamjms.2019.418.


MULTIGLANDULAR PARATHYROID GLAND DISEASE: AN INCIDENTAL DISCOVERY IN NORMOCALCEMIC PATIENTS DURING THYROID SURGERY.

Cherenko S, Dinets A, Bandura G, Sheptuha S, Larin O Acta Endocrinol (Buchar). 2019; 13(3):349-355.

PMID: 31149199 PMC: 6516574. DOI: 10.4183/aeb.2017.349.


Practice Patterns in Parathyroid Surgery: A Survey of Asia-Pacific Parathyroid Surgeons.

Chen R, Oh H, Parameswaran R, Gorelik A, Miller J World J Surg. 2019; 43(8):1964-1971.

PMID: 30941454 DOI: 10.1007/s00268-019-04990-4.


Minimally Invasive Parathyroidectomy without Intraoperative PTH Performed after Positive Ultrasonography as the only Diagnostic Method in Patients with Primary Hyperparathyroidism.

Schneider R, Hinrichs J, Meier B, Walz M, Alesina P World J Surg. 2019; 43(6):1525-1531.

PMID: 30847526 DOI: 10.1007/s00268-019-04944-w.


Intraoperative PTH May Not Be Necessary in the Management of Primary Hyperparathyroidism Even with Only One Positive or Only Indeterminate Preoperative Localization Studies.

Najafian A, Kahan S, Olson M, Tufano R, Zeiger M World J Surg. 2017; 41(6):1500-1505.

PMID: 28224198 DOI: 10.1007/s00268-017-3871-4.


References
1.
Heath 3rd H, Hodgson S, Kennedy M . Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980; 302(4):189-93. DOI: 10.1056/NEJM198001243020402. View

2.
Udelsman B, Udelsman R . Surgery in primary hyperparathyroidism: extensive personal experience. J Clin Densitom. 2013; 16(1):54-9. DOI: 10.1016/j.jocd.2012.11.007. View

3.
Grant C, Thompson G, Farley D, van Heerden J . Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005; 140(5):472-8. DOI: 10.1001/archsurg.140.5.472. View

4.
Lee J, Inabnet 3rd W . The surgeon's armamentarium to the surgical treatment of primary hyperparathyroidism. J Surg Oncol. 2005; 89(3):130-5. DOI: 10.1002/jso.20183. View

5.
Ruda J, Hollenbeak C, Stack Jr B . A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005; 132(3):359-72. DOI: 10.1016/j.otohns.2004.10.005. View